Endogenous Plasma α-Tocopherol Concentration Indicates Human Health Condition
Main Article Content
Abstract
The level of endogenous α-tocopherol concentration in plasma of fifty-eight smokers and non-smoking healthy male volunteers, two lung cancer patients, and forty-six healthy volunteers (five males and nine females as control and the rest with vitamin E supplement in the dosage of 100, 200 or 400 IU/D, respectively), were quantified by the developed HPLC method. It was found that in healthy condition, endogenous plasma α-tocopherol level of either smokers or non-smokers were still within the optimal of 7.0 – 19.0 µg/ml. In severe health condition, such as lung cancer patients, the average endogenous plasma α-tocopherol concentration was only 5.0 µg/ml. Vitamin E supplement of 200 and 400 IU/D could significantly improve plasma α-tocopherol level to 11.0 – 26.0 µg/ml and 16.0 – 31.0 µg/ml, respectively. They were significantly higher than the control group (p = 0.007). However, plasma α-tocopherol concentration of volunteer with 400 IU daily up taken vitamin E was not significantly higher than those administered vitamin E 200 IU/day (p = 0.095). No statistically significant difference of endogenous plasma α-tocopherol between the control group (7.5 – 17.6 µg/ml) and those with vitamin E 100 IU/D (9.9 – 19.6 µg/ml) was observed (p = 0.317). For 100 IU/D of vitamin E supplement, plasma α-tocopherol concentration did not increase significantly but only maintained within the optimal range. Therefore, it would be confirmed that the level of endogenous plasma α-tocopherol concentration of each individual could possibly be used as an additional parameter for indicating health condition.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Journal of TCI is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence, unless otherwise stated. Please read our Policies page for more information.
References
Curran FJM, Sattar N, Talwar D, Baxter JN,. Imrie CW. 2000. Relationship of carotenoid and vitamins A and E with the acute inflammatory response in acute pancreatitis. Br. J. Sur. 87(3): 301-305.
Garrow JS, James WP, Ralph A. 2000. Human nutrition and dietetics 10th ed. Churchill Livingstone. UK, pp226.
Graham S, Zielezny M, Marshall J, Priore R, Freudenheim J, Brasure J, et al,. 1992. Diet in the epidemiology of postmenopausal breast cancer in the New York State Cohort. Am. J. Epidemiol. 136(11): 1327-1337.
Handelman GJ. 1997. High dose vitamin supplements for cigarette smokers: caution is indicated. Nutr Rev. 55(10): 369-370.
Jialal I, Fuller CJ. 1995. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can. J. Cardiol. 11 suppl G: 97G.
Leppala JM, Virtamo J, Fogelholm R, Huttunen JK, Albanes D, Taylor PR, et al. 2000. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc. Biol. 20(1): 230-235.
Meier PC, Zund RE. 2000. Linear regression. In Statistical methods in analytical chemistry, 2 nd ed, John Wiley & Sons: U.S.A. pp 120.
Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. 1986. Serum beta-carotene, vitamin A and E, selenium and the risk of lung cancer. N. Engl. J. Med. 315(13): 1250-1254.
Miyamoto H, Araya Y, Ito M, Isobe H, Dosaka H, Shimizu T, et al,. 1987. Serum selenium and vitamin E concentrations in families of lung cancer patients. Cancer 60: 1159-1162.
Nirungsan K, Thongnopnua P. 2006. Simple and rapid high-performance liquid chromatographic method for endogenous -tocopherol determination in human plasma. Biomed. Chromatogr. 20: 774-781.
Palan PR, Mikhail MS, Goldberg GL, Basu J, Runowicz CD, Romney SL. 1996. Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer. Clin. Can. Res. 2(1): 181-185.
Paolisso G, Barbieri M, Rizzo MR, Manzella D. 2001. Should we recommend the therapeutically use of vitamin E in diabetes patients? Environ Toxicol Pharmacol 10: 159-165.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. 1993. Vitamin E consumption and the risk of coronary heart disease in men. N.Eng.J.Med. 328: 1450-1456.
Slattery ML, Edwards SL, Anderson K, Caan B. 1998. Vitamin E and colon cancer: Is there an association? Nutr. Cancer 30: 201-206.
Traber MG, Packer L. 1995. Vitamin E: beyond antioxidant function. Am.J.Clin.Nutr. 62: 1501S-1509S.